| RS1057516136 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057516138 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1057516139 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516140 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516141 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516142 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516144 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516145 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516149 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516150 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516151 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516153 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516156 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516157 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516158 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516159 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516161 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516163 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516164 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516165 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516166 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516167 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516168 |
FOXL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharophimosis, ptosis |
| RS1057516170 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516172 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516173 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516174 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516175 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516176 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516178 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516179 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516180 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516181 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516182 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516183 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516184 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516185 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1057516187 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1057516189 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1057516191 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly |
| RS1057516192 |
AVP
|
Health Risk |
Likely pathogenic |
Neurohypophyseal diabetes insipidus, Neurohypophyseal diabetes insipidus |
| RS1057516193 |
SLC38A8
|
Health Risk |
Likely pathogenic |
Foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome, Foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome |
| RS1057516194 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1057516195 |
DRAM2
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 21, Cone-rod dystrophy 21 |
| RS1057516196 |
LMX1B
|
Health Risk |
Likely pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS1057516197 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1057516198 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS1057516199 |
CACNA1F
|
Health Risk |
Likely pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS1057516201 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1057516202 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1057516203 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1057516204 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1057516206 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1057516207 |
CLCNKB
|
Health Risk |
Pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS1057516208 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1057516210 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Familial Mediterranean fever |
| RS1057516211 |
AIFM1
|
Health Risk |
Pathogenic |
Severe X-linked mitochondrial encephalomyopathy, Severe X-linked mitochondrial encephalomyopathy |
| RS1057516212 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1057516215 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1057516216 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Fetal cystic hygroma |
| RS1057516217 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1057516218 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1057516219 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1057516221 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1057516222 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1057516223 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1057516224 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1057516225 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1057516226 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1057516227 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1057516228 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1057516229 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057516230 |
ALPL
|
Health Risk |
Pathogenic |
Infantile hypophosphatasia, Hypophosphatasia |
| RS1057516231 |
ACADS
|
Health Risk |
Likely pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1057516232 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1057516233 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1057516235 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057516236 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1057516238 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057516240 |
BBS10
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome 10 |
| RS1057516241 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1057516242 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1057516243 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1057516245 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1057516246 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1057516247 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS1057516248 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS1057516249 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1057516250 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1057516251 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1057516252 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1057516253 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1057516254 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1057516255 |
BCS1L
|
Health Risk |
Pathogenic |
GRACILE syndrome, Mitochondrial complex III deficiency nuclear type 1 |
| RS1057516256 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1057516257 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1057516258 |
FKTN
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1057516259 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1057516260 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1057516261 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |